Creatine Supplementation in Preclinical Models Receiving Immune Checkpoint Inhibitor Therapy: A Systematic Review
Abstract
Creatine supplementation is widely used for its ergogenic benefits but has recently garnered interest for its immunomodulatory properties, particularly its capacity to enhance CD8+ T-cell bioenergetics through SLC6A8-mediated transport and phosphocreatine-dependent ATP (adenosine triphosphate) buffering. Emerging preclinical evidence suggests that creatine may potentiate antitumor immunity and augment the efficacy of immune checkpoint inhibitor (ICI) therapies. Conflicting reports of creatine-associated metastasis in select tumor models have raised uncertainty regarding its role in oncologic settings. This review synthesizes current preclinical evidence to assess whether creatine exerts beneficial, neutral, or detrimental effects across experimental oncologic models treated with immune checkpoint therapy. A total of 230 articles were screened, and 5 studies were included within this systematic review. Current preclinical evidence suggests that creatine supplementation may exert beneficial immunomodulatory and antitumor effects when combined with PD-1 blockade, largely by enhancing T-cell metabolic fitness and macrophage-driven inflammatory responses. However, the potential for metastasis in select tumor types poses a risk to the administration of a creatine supplement. This systematic review emphasizes the absence of human data, highlighting a critical knowledge gap. Rigorous mechanistic studies and early-phase clinical trials are essential to determine whether creatine can…
How strong is the evidence?
Evidence Hub reads this as a systematic review. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Biportal endoscopic versus microscopic lumbar decompressive laminectomy in patients with spinal stenosis: A randomized controlled trial
- A whey protein-based multi-ingredient nutritional supplement stimulates gains in lean body mass and strength in healthy older men: A randomized controlled trial
- Supplement-based nutritional strategies to tackle frailty: A multifactorial, double-blind, randomized placebo-controlled trial
- A randomized, double-blind, placebo-controlled, proof-of-concept trial of creatine monohydrate as adjunctive treatment for bipolar depression
- Creatine supplementation (3 g/day) and bone health in older women: a 2-year, randomized, placebo-controlled trial
- A Multi-Ingredient Nutritional Supplement in Combination With Resistance Exercise and High-Intensity Interval Training Improves Cognitive Function and Increases N-3 Index in Healthy Older Men: A Randomized Controlled Trial
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.